C.M. Bidwell & Associates’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-22
Closed -$609 – 490
2024
Q3
$609 Hold
22
– – ﹤0.01% 456
2024
Q2
$525 Sell
22
-10
-31% -$235 ﹤0.01% 438
2024
Q1
$563 Hold
32
– – ﹤0.01% 436
2023
Q4
$505 Buy
+32
New +$330 ﹤0.01% 448

Other funds holding ASPN

C.M. Bidwell & Associates's ASPN Position: Q4 2024 in Review

C.M. Bidwell & Associates sold out of Aspen Aerogels (ASPN) in Q4 2024, closing a stake of 22 shares — an estimated $609 sold.

C.M. Bidwell & Associates first reported a position in ASPN in Q4 2023 and held it in 4 quarters. The position peaked at $609 in Q3 2024. 231 funds tracked by Wall St. Rank hold ASPN as of Q4 2024.

  • C.M. Bidwell & Associates reported no remaining Aspen Aerogels position as of Q4 2024 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 22 Aspen Aerogels shares in Q4 2024, an estimated $609.
  • C.M. Bidwell & Associates first reported a position in Aspen Aerogels in Q4 2023 and held it in 4 quarters.
  • C.M. Bidwell & Associates's Aspen Aerogels position peaked at $609 in Q3 2024.
  • 231 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2024.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.